-+ 0.00%
-+ 0.00%
-+ 0.00%

Custom Health Q3-2026 net loss widens 87% to USD 11.73 million; Q3-2026 revenue more than triples to USD 14.4 million

PUBT·11/16/2026 22:40:05
Custom Health Q3-2026 net loss widens 87% to USD 11.73 million; Q3-2026 revenue more than triples to USD 14.4 million
  • Custom Health’s Q3-2026 net loss widened 87% to USD 11.73 million, primarily due to higher finance costs and debt-modification losses.
  • Revenue more than tripled to USD 14.4 million, reflecting the first full quarter of contributions from InnovativeRx.
  • The acquisition of Spencer Health Solutions closed September 4, bringing its in-home medication dispensing technology and intellectual property fully in-house.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Custom Health Holdings Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611161737NEWSFILECNPR____20261116_324410_1) on November 16, 2026, and is solely responsible for the information contained therein.